These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
206 related items for PubMed ID: 38908555
1. Validation of screening instruments for common mental disorders and suicide risk in south African primary care settings. Stockton MA, Mazinyo EW, Mlanjeni L, Sweetland AC, Scharf JY, Nogemane K, Ngcelwane N, Basaraba C, Bezuidenhout C, Sansbury G, Olivier D, Grobler C, Wall MM, Medina-Marino A, Nobatyi P, Wainberg ML. J Affect Disord; 2024 Oct 01; 362():161-168. PubMed ID: 38908555 [Abstract] [Full Text] [Related]
2. Diagnostic Accuracy of Mental Health Screening Tools After Mild Traumatic Brain Injury. Gitaari M, Mikolic A, Panenka WJ, Silverberg ND. JAMA Netw Open; 2024 Jul 01; 7(7):e2424076. PubMed ID: 39042406 [Abstract] [Full Text] [Related]
3. Comparison of mental health screening tools for detecting antenatal depression and anxiety disorders in South African women. van Heyningen T, Honikman S, Tomlinson M, Field S, Myer L. PLoS One; 2018 Jul 01; 13(4):e0193697. PubMed ID: 29668725 [Abstract] [Full Text] [Related]
4. Validation of screening tools for depression and anxiety disorders in a primary care population with high HIV prevalence in Zimbabwe. Chibanda D, Verhey R, Gibson LJ, Munetsi E, Machando D, Rusakaniko S, Munjoma R, Araya R, Weiss HA, Abas M. J Affect Disord; 2016 Jul 01; 198():50-5. PubMed ID: 27011359 [Abstract] [Full Text] [Related]
5. Psychometric Validation of PHQ-9 and GAD-7 in Filipino Migrant Domestic Workers in Macao (SAR), China. Garabiles MR, Lao CK, Yip P, Chan EWW, Mordeno I, Hall BJ. J Pers Assess; 2020 Jul 01; 102(6):833-844. PubMed ID: 31361153 [Abstract] [Full Text] [Related]
6. Detecting Depression and Anxiety Among Adolescents in South Africa: Validity of the isiXhosa Patient Health Questionnaire-9 and Generalized Anxiety Disorder-7. Marlow M, Skeen S, Grieve CM, Carvajal-Velez L, Åhs JW, Kohrt BA, Requejo J, Stewart J, Henry J, Goldstone D, Kara T, Tomlinson M. J Adolesc Health; 2023 Jan 01; 72(1S):S52-S60. PubMed ID: 36274021 [Abstract] [Full Text] [Related]
7. Validation of brief screening measures for depression and anxiety in young people with substance use disorders. Bentley KH, Sakurai H, Lowman KL, Rines-Toth L, McKowen J, Pedrelli P, Evins AE, Yule AM. J Affect Disord; 2021 Mar 01; 282():1021-1029. PubMed ID: 33601674 [Abstract] [Full Text] [Related]
8. A systematic review of validated screening tools for anxiety disorders and PTSD in low to middle income countries. Mughal AY, Devadas J, Ardman E, Levis B, Go VF, Gaynes BN. BMC Psychiatry; 2020 Jun 30; 20(1):338. PubMed ID: 32605551 [Abstract] [Full Text] [Related]
9. Validation of the 10-item Centre for Epidemiological Studies Depression Scale (CES-D-10) in Zulu, Xhosa and Afrikaans populations in South Africa. Baron EC, Davies T, Lund C. BMC Psychiatry; 2017 Jan 09; 17(1):6. PubMed ID: 28068955 [Abstract] [Full Text] [Related]
11. Validation of a brief mental health screening tool for common mental disorders in primary healthcare. Bhana A, Mntambo N, Gigaba SG, Luvuno ZPB, Grant M, Ackerman D, Ntswe E, Nomathemba M, Petersen I. S Afr Med J; 2019 Mar 29; 109(4):278-283. PubMed ID: 31084695 [Abstract] [Full Text] [Related]
14. Optimizing screening for depression, anxiety disorders, and post-traumatic stress disorder in inpatient addiction treatment: A preliminary investigation. Levitt EE, Syan SK, Sousa S, Costello MJ, Rush B, Samokhvalov AV, McCabe RE, Kelly J, MacKillop J. Addict Behav; 2021 Jan 29; 112():106649. PubMed ID: 32979691 [Abstract] [Full Text] [Related]
15. Validation of the Patient Health Questionnaire-4 (PHQ-4) to screen for depression and anxiety in the Greek general population. Christodoulaki A, Baralou V, Konstantakopoulos G, Touloumi G. J Psychosom Res; 2022 Sep 29; 160():110970. PubMed ID: 35728338 [Abstract] [Full Text] [Related]
16. Adaptation and initial validation of the Patient Health Questionnaire - 9 (PHQ-9) and the Generalized Anxiety Disorder - 7 Questionnaire (GAD-7) in an Arabic speaking Lebanese psychiatric outpatient sample. Sawaya H, Atoui M, Hamadeh A, Zeinoun P, Nahas Z. Psychiatry Res; 2016 May 30; 239():245-52. PubMed ID: 27031595 [Abstract] [Full Text] [Related]
17. Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis. Hitchon CA, Zhang L, Peschken CA, Lix LM, Graff LA, Fisk JD, Patten SB, Bolton J, Sareen J, El-Gabalawy R, Marriott J, Bernstein CN, Marrie RA. Arthritis Care Res (Hoboken); 2020 Aug 30; 72(8):1130-1139. PubMed ID: 31199570 [Abstract] [Full Text] [Related]
18. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: The PHQ-2, GAD-2, and K-6. Staples LG, Dear BF, Gandy M, Fogliati V, Fogliati R, Karin E, Nielssen O, Titov N. Gen Hosp Psychiatry; 2019 Aug 30; 56():13-18. PubMed ID: 30508772 [Abstract] [Full Text] [Related]
19. Validation of the Patient Health Questionnaire-9 and the Generalized Anxiety Disorder-7 in Lithuanian individuals with anxiety and mood disorders. Stanyte A, Fineberg NA, Podlipskyte A, Gecaite-Stonciene J, Macijauskiene J, Steibliene V, Burkauskas J. J Psychiatr Res; 2023 Aug 30; 164():221-228. PubMed ID: 37385000 [Abstract] [Full Text] [Related]